Compare AANJANEYA LIFECARE with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PANACEA BIOTECH DR. DATSONS LABS/
PANACEA BIOTECH
 
P/E (TTM) x -10.9 9.4 - View Chart
P/BV x 0.2 3.7 4.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   PANACEA BIOTECH
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PANACEA BIOTECH
Mar-19
DR. DATSONS LABS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs126354 35.5%   
Low Rs31138 22.4%   
Sales per share (Unadj.) Rs133.074.6 178.4%  
Earnings per share (Unadj.) Rs0.26.7 2.3%  
Cash flow per share (Unadj.) Rs6.615.5 42.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.857.2 225.1%  
Shares outstanding (eoy) m31.6661.25 51.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.3 17.8%   
Avg P/E ratio x516.136.8 1,401.9%  
P/CF ratio (eoy) x11.815.9 74.6%  
Price / Book Value ratio x0.64.3 14.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,47715,061 16.4%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m561,471 3.8%   
Avg. sales/employee Rs ThNM1,973.6-  
Avg. wages/employee Rs ThNM635.6-  
Avg. net profit/employee Rs ThNM176.8-  
INCOME DATA
Net Sales Rs m4,2114,567 92.2%  
Other income Rs m7945 175.7%   
Total revenues Rs m4,2894,612 93.0%   
Gross profit Rs m5692,030 28.0%  
Depreciation Rs m204540 37.9%   
Interest Rs m4301,048 41.0%   
Profit before tax Rs m13486 2.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m677 7.9%   
Profit after tax Rs m5409 1.2%  
Gross profit margin %13.544.4 30.4%  
Effective tax rate %48.015.9 302.9%   
Net profit margin %0.19.0 1.3%  
BALANCE SHEET DATA
Current assets Rs m6,8522,415 283.8%   
Current liabilities Rs m6,7119,077 73.9%   
Net working cap to sales %3.3-145.9 -2.3%  
Current ratio x1.00.3 383.9%  
Inventory Days Days16165 247.1%  
Debtors Days Days31871 449.1%  
Net fixed assets Rs m3,6738,333 44.1%   
Share capital Rs m31761 516.5%   
"Free" reserves Rs m3,7613,443 109.2%   
Net worth Rs m4,0783,504 116.4%   
Long term debt Rs m1,671461 362.3%   
Total assets Rs m12,63313,755 91.8%  
Interest coverage x1.01.5 70.3%   
Debt to equity ratio x0.40.1 311.3%  
Sales to assets ratio x0.30.3 100.4%   
Return on assets %3.410.6 32.5%  
Return on equity %0.111.7 1.0%  
Return on capital %7.738.7 19.8%  
Exports to sales %22.920.9 109.6%   
Imports to sales %14.38.1 175.5%   
Exports (fob) Rs m964954 101.1%   
Imports (cif) Rs m602372 161.8%   
Fx inflow Rs m9641,203 80.1%   
Fx outflow Rs m607467 130.1%   
Net fx Rs m357736 48.5%   
CASH FLOW
From Operations Rs m1,3451,049 128.2%  
From Investments Rs m-2,256-54 4,216.1%  
From Financial Activity Rs m-1,200-1,011 118.6%  
Net Cashflow Rs m-2,111-20 10,714.2%  

Share Holding

Indian Promoters % 4.5 74.5 6.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.6 -  
FIIs % 1.4 1.3 103.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.6 398.7%  
Shareholders   20,807 10,259 202.8%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SUVEN LIFE SCIENCES  NEULAND LABS  PIRAMAL ENTERPRISES  TTK HEALTHCARE  SUN PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Higher; Dow Futures Up by 39 Points(12:30 pm)

Share markets in India are presently trading on a strong note. The BSE Sensex is trading up by 337 points, up 0.7% at 50,129 levels.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - PFIZER COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS